Clinical Trials in Maine (ME) | Maine Clinical Drug Trials & Studies

You are viewing Clinical Trials In Maine

Have multiple conditions? Click here

Showing 1-100 of 304

There are 304 trials in Maine

Name	City	State	Zip
An Open-Label Study of Trastuzumab-MCC-DM1 (T-DM1) vs. Capecitabine + Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer	York	ME	03909
A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma	York	ME	03909
Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain	York	ME	03909
RED-HFâ„¢ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial	South Portland	ME
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications	South Portland	ME
Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 145 in Subjects With Hyperlipidemia on Stable Doses of a Statin	South Portland	ME
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus	South Portland	ME
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection	South Portland	ME
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin	South Portland	ME
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI	South Portland	ME	04106
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia	Scarborough	ME	04074
Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma	Scarborough	ME	04074
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Scarborough	ME	04074
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Scarborough	ME	04074
Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (Paradigm Trial)	Scarborough	ME	04074
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection	Scarborough	ME	04074
Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome	Scarborough	ME	04074
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery	Scarborough	ME	04074
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors	Scarborough	ME	04074
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	Scarborough	ME	04074
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Scarborough	ME	04074
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Scarborough	ME	04074
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Scarborough	ME	04074
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Scarborough	ME	04074
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer	Scarborough	ME	04074
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Scarborough	ME	04074
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Scarborough	ME	04074
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer	Scarborough	ME	04074
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor	Scarborough	ME	04074
A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer	Scarborough	ME	04074
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib	Scarborough	ME	04074
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Scarborough	ME	04074
A Trial of Patients With Metastatic Adenocarcinoma of the Pancreas	Scarborough	ME	04074
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression	Scarborough	ME	04074
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder	Scarborough	ME	04074
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Scarborough	ME	04074
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	Scarborough	ME	04074
Diabetic Peripheral Neuropathic Pain (DPNP)	Scarborough	ME	04074
Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain	Scarborough	ME	04074
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression	Scarborough	ME	04074
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin	Scarborough	ME	04074
A Study of LY2140023 in Patients With Schizophrenia	Scarborough	ME	04074
Crossover Post-herpetic Neuralgia (PHN)	Scarborough	ME	04074
A Study in Prevention of Re-emergence of Depression Symptoms	Scarborough	ME	04074
Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin	Scarborough	ME	04074
A Safety Study in Patients With Advanced Solid Tumors	Scarborough	ME	04074
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma	Scarborough	ME	04074
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	Scarborough	ME	04074
Study of Kidney Tumors in Young Patients	Scarborough	ME	04074
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma	Scarborough	ME	04074
Combination Study of BMS-754807 and ErbituxÂ® in Subjects With Advanced or Metastatic Solid Tumors	Scarborough	ME	04074
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)	Scarborough	ME	04074
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Scarborough	ME	04074
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy	Scarborough	ME	04074
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer	Scarborough	ME	04074
Study of Patients With Advanced Non-Small Cell Lung Cancer	Scarborough	ME	04074
A Study in Relapse Prevention of Treatment-resistant Depression	Scarborough	ME	04074
A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder	Scarborough	ME	04074
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer	Scarborough	ME	04074
A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms	Scarborough	ME	04074
A Study in Patients With Type 2 Diabetes Mellitus	Scarborough	ME	04074
A Study in Head and Neck Cancer	Scarborough	ME	04074
Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)	Scarborough	ME	04074
A Study in Schizophrenia Patients	Scarborough	ME	04074
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer	Scarborough	ME	04074
Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome	Scarborough	ME	04074
A Study in Men With Benign Prostatic Hyperplasia	Scarborough	ME	04074
Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer	Scarborough	ME	04074
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer	Scarborough	ME	04074
A Study in Patients With Diabetic Kidney Disease	Scarborough	ME	04074
A Study of LY2584702 With Erlotinib or Everolimus in Patients With Solid Tumors	Scarborough	ME	04074
First in Human Study to Determine the Safety, Tolerability and Preliminary Effectiveness of MDX-1338 (BMS 936564) in Subjects With Acute Myelogenous Leukemia (AML)	Scarborough	ME	04074
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)	Scarborough	ME	04074
A Long-Term, Open-Label, Study on Schizophrenia	Scarborough	ME	04074
A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (PDE5) Inhibitors	Scarborough	ME	04074
Pediatric Catheter-related Thrombosis Imaging Study	Scarborough	ME	04074
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Scarborough	ME	04074
A Study in Benign Prostatic Hyperplasia	Scarborough	ME	04074
A Study in Second Line Non Small Cell Lung Cancer	Scarborough	ME	04074
A Study in Second Line Metastatic Colorectal Cancer	Scarborough	ME	04074
A Study in Patients With Rheumatoid Arthritis on Background Methotrexate Therapy	Scarborough	ME	04074
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia	Scarborough	ME	04074
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter	Scarborough	ME	04074
A Study of LY2127399 in Patients With Systemic Lupus Erythematosus	Scarborough	ME	04074
A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate	Scarborough	ME	04074
A Rheumatoid Arthritis Study in Patients	Scarborough	ME	04074
A Study in Patients With Rheumatoid Arthritis	Scarborough	ME	04074
A Study of LY2127399 in Patients With Systemic Lupus Erythematosus	Scarborough	ME	04074
A Study in Patients With Acute Leukemia	Scarborough	ME	04074
A Study for Patients With Acute Leukemia	Scarborough	ME	04074
Study of Insulin Lispro in Patients With Inadequately Controlled Type 2 Diabetes	Scarborough	ME	04074
Dasatinib Combo With SMO Inhibitor (BMS-833923)	Scarborough	ME	04074
Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors	Scarborough	ME	04074
A Study in Pediatric Patients With Generalized Anxiety Disorder	Scarborough	ME	04074
OPT - Phase IV Long Term Maintenance Study of Aripiprazole for the Treatment of Irritability Associated With Autistic Disorder	Scarborough	ME	04074
A Study in Non-Small Cell Lung Cancer	Scarborough	ME	04074
Multiple Ascending Dose of BMS-911543	Scarborough	ME	04074
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome	Scarborough	ME	04074
A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer	Scarborough	ME	04074
A Study of LY2157299 in Patients With Hepatocellular Carcinoma	Scarborough	ME	04074

View Clinical Trial Facilities in Maine

Showing 1-100 of 304